CD4 and tuberculosis: This observation aligns with clinical data comparing various candidate TB vaccines (MVA85A, AERAS-402, H1:IC31, H56:IC31, M72/AS01, ID93/GLA-SE, and BCG) (14), where all vaccines triggered antigen-specific CD4+ T-cell responses, predominantly featuring Th1 cytokine production.